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Evan Eichler
It is my honor to introduce the 2005Curt Stern awardee,
Patrick Brown, M.D., Ph.D. Established in 2001, the Curt
Stern Award recognizes scientiﬁc excellence in the ﬁeld of
human genetics on the basis of research performed over
the last 10 years. In particular, this award is given to a re-
cipient not only as amark of outstanding scientiﬁc achieve-
ment, but also to a researcher who has pioneered an area
of research that has signiﬁcantly advanced the ﬁeld of
human genetics. The revolutionary research of Dr. Brown
in both the technological development and application
of gene-based expression microarrays eminently qualiﬁes
him for this award.
Dr. Patrick Brown is a professor in the Department of
Biochemistry at Stanford University School of Medicine
and an Investigator of the Howard Hughes Medical Insti-
tute. He began his career in the ﬁeld of chemistry, grad-
uating with his B.A. (honors) from the University of Chi-
cago in 1976. He then moved to the Department of Bio-
chemistry, where he was awarded his Ph.D. on studies of
DNA topoisomerases, under the mentorship of Nicholas
Cozzarelli, Ph.D. After completing his M.D. and pediatric
residency, he moved to the University of California–San
Francisco, where he worked as a postdoctoral fellow in the
laboratory of Drs. J. Michael Bishop and Harold E. Varmus.
In 1988, he joined the faculty of the Department of Bio-
chemistry, Stanford University School of Medicine, as an
assistant professor and an investigator of the Howard
Hughes Medical Institute.
In 1995, he was the lead investigator of two seminal
publications1,2 that ushered in the era of gene-expression–
microarray analysis and revolutionizedmolecular biology.
Although this initial work focused on detailing the tran-
scriptional program of yeast and Arabidopsis, the utility of
microarray technology to understanddevelopmental,phys-
iological, and pathological processes in humans became
apparent. The development of cDNA microarrays to in-
terrogate the expression differences of tens of thousands
of genes simultaneously represents both a technological
and a conceptual advance of our ﬁeld. His work to sys-
tematically characterize variation in gene expression an-
ticipated the next logical extension of the Human Ge-
nome Project.
Consequently, Dr. Brown and his collaborators have
paved the way, demonstrating the utility of gene-expres-
sion microarrays for pinpointing transcriptional differ-
ences between normal and cancer tissues,3–5 characterizing
transcriptional differences due to stress or pharmacolog-
ical agents,6 and identifying genes that distinguish devel-
opment pathways of normal tissues.78–9 Due largely to the
efforts of Dr. Brown, his students, and postdoctoral fel-
lows, the use of gene-expression microarrays has become
commonplace—a technology recognized as one of the
“most powerful tools in modern biology.”10 Dr. Brown’s
dedication to the unconditional public release of data, pub-
lications, and protocols has played a pivotal role inmaking
this technology accessible to countless labs around the
world.
His work has had far-reaching implications and has
changed the way we think about problems in human ge-
netics, from a largely reductionist to a holistic perspective.
In an interview in 2002, he was quoted as saying “the
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studies that tend to really have lasting value tend to be
the ones where the approach taken at the outset was sys-
tematic and the kind of data collected was broader than
might have been dictated by a particular narrow question
being asked.”11
Dr. Brown’s career and achievements have epitomized
that philosophy.
In my opinion, the true mark of the most successful
scientist occurs when their invention and their contribu-
tions become so commonly accepted that the time prior
to their invention becomes quickly forgotten. Such a par-
adigm shift has occurred with respect to expression anal-
ysis andmicroarray technology in human genetics. Today,
we recognize Dr. Pat Brown for his pioneering contribu-
tions to this revolution. On behalf of the American Society
of Human Genetics and as a member of the Awards Com-
mittee, I am privileged to present the 2005 Curt Stern
Award to Dr. Patrick O. Brown.
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